Literature DB >> 10910344

A triclosan-resistant bacterial enzyme.

R J Heath1, C O Rock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10910344     DOI： 10.1038/35018162

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  83 in total

1.  Triclosan and fatty acid synthesis in Plasmodium falciparum: new weapon for an old enemy.

Authors:  G P Bhat; N Surolia
Journal:  J Biosci       Date:  2001-03       Impact factor: 1.826

2.  Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.

Authors:  Shahila Mehboob; Kirk E Hevener; Kent Truong; Teuta Boci; Bernard D Santarsiero; Michael E Johnson
Journal:  J Med Chem       Date:  2012-06-08       Impact factor: 7.446

3.  Antibacterial activity of a triclosan-containing resin composite matrix against three common oral bacteria.

Authors:  Andreas Rathke; Rainer Staude; Rainer Muche; Bernd Haller
Journal:  J Mater Sci Mater Med       Date:  2010-07-17       Impact factor: 3.896

4.  Determination of absolute configuration and binding efficacy of benzimidazole-based FabI inhibitors through the support of electronic circular dichroism and MM-GBSA techniques.

Authors:  Jinhong Ren; Tina L Mistry; Pin-Chih Su; Shahila Mehboob; Robel Demissie; Leslie Wo-Mei Fung; Arun K Ghosh; Michael E Johnson
Journal:  Bioorg Med Chem Lett       Date:  2018-04-22       Impact factor: 2.823

Review 5.  The reductase steps of the type II fatty acid synthase as antimicrobial targets.

Authors:  Yong-Mei Zhang; Ying-Jie Lu; Charles O Rock
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

6.  Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.

Authors:  Jun Saito; Mototsugu Yamada; Takashi Watanabe; Hideo Kitagawa; Yasuo Takeuchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-05-31

7.  Discovery of a novel and potent class of FabI-directed antibacterial agents.

Authors:  David J Payne; William H Miller; Valerie Berry; John Brosky; Walter J Burgess; Emile Chen; Walter E DeWolf; Andrew P Fosberry; Rebecca Greenwood; Martha S Head; Dirk A Heerding; Cheryl A Janson; Deborah D Jaworski; Paul M Keller; Peter J Manley; Terrance D Moore; Kenneth A Newlander; Stewart Pearson; Brian J Polizzi; Xiayang Qiu; Stephen F Rittenhouse; Courtney Slater-Radosti; Kevin L Salyers; Mark A Seefeld; Martin G Smyth; Dennis T Takata; Irene N Uzinskas; Kalindi Vaidya; Nicola G Wallis; Scott B Winram; Catherine C K Yuan; William F Huffman
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 8.  Bacterial fatty acid metabolism in modern antibiotic discovery.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-23       Impact factor: 4.698

Review 9.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Benzimidazole-Based FabI Inhibitors: A Promising Novel Scaffold for Anti-staphylococcal Drug Development.

Authors:  Tina L Mistry; Lena Truong; Arun K Ghosh; Michael E Johnson; Shahila Mehboob
Journal:  ACS Infect Dis       Date:  2016-10-27       Impact factor: 5.084
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.